Product Images Darifenacin

This appears to be a graph showing the percentage of patients with certain genotypes (EMs and PMs) who were administered doses of either 7.5mg or 15mg. The graph shows the percentage of patients who achieved a certain level of drug concentration over a certain amount of time after the dose. The time is measured in hours and ranges from 0 to 24 hours. The medication name, patient condition, or purpose of the graph is not available.*

This is a medicine called "Darifenacin Extended-release tablets" containing 15mg of darifenacin. It is usually prescribed as one tablet daily or as directed by a physician. The container should be kept tightly closed and stored at 25°C, protected from light. Manufacturing and distribution is done by PolyGen Pharmaceuticals Inc.*

This is a pharmaceutical label for Darifenacin extended-release tablets, containing 30 tablets, each with 17.858 mg of Darifenacin equivalent to provide 15 mg of Darifenacin, with a recommended dosage of one tablet daily or as directed by a physician. The pharmacist is advised to dispense patient information separately to each patient. The drug should be kept out of reach of children, and stored at 25°C (77°F) and protected from light. It is manufactured and distributed by PolyGen Pharmaceuticals Inc. in Edgewood, NY 11717, USA.*

This is a description of a medication called Extended-release Lirdi Iomaton. Each tablet contains 15mg of darifenacin hydrobromide. The package insert should be consulted as directed by a physician. The medication should be kept away from children and stored at a temperature of 25°C (7°F) in a tightly closed container, protected from light. The medication is produced and distributed by PolyGen Pharmaceuticals Inc. It is available in a container of 90 tablets and is only available with a prescription.*

This is a description of Darifenacin Extended-release Tablets 7.5 mg, manufactured and distributed by PolyGen Pharmaceuticals Inc. Each tablet contains 8920 mg of darifenacin hydrobromide, providing 7.5mg of darifenacin. The recommended dosage is one tablet daily or as directed by a physician. The tablets come in a container holding 1000 tablets and should be stored at 25°C (77°F) and protected from light. The pharmacist needs to dispense the patient information separately to each patient. The container is not intended for household use.*

This is a pharmaceutical label for Darifenacin Extended-release tablets with 90 tablets per bottle. Each tablet contains 8929 g of darfenacin hydrobromide equivalent to providing 7.5 mg darifenacin. It also mentions that the full prescribing information is included within the package. The drug is for prescription only, and it should be kept away from children while being stored at room temperature and protected from light. It is manufactured and distributed by Polygen Pharmaceuticals Inc. in Edgewood, NY.*